Clinical Trial Update: Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating fulvestrant with or without an AKT inhibitor in advanced aromatase inhibitor-resistant estrogen receptor-positive breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• AKT inhibitor (AKT inhibitor)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Velindre NHS Trust | Conditions: Estrogen Receptor Positive Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING